EGFR and nasopharyngeal carcinoma: Univariate analysis showed that T stage, targeted drug therapy, induction chemotherapy cycles, neutrophils, monocytes, platelets, hemoglobin, NLR, PLR, and LMR were associated with the recent outcomes of EGFR-positive NPC patients (p < 0.05), as shown in Table 2.